Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
GIP is an important insulinotropic hormone (incretin) that has also
been implicated in fat metabolism. There is controversy regarding the
actions of GIP on adipocytes. In the current study, the existence of
GIP receptors and effects of GIP on lipolysis were studied in
differentiated 3T3-L1 cells. GIP receptor messenger RNA was detected by
RT-PCR and RNase protection assay. Receptors were detected in binding
studies (IC50 26.7 ± 0.7 nm). GIP
stimulated glycerol release with an EC50 of 3.28 ±
0.63 nm. GIP (10−9–10−7
m) + IBMX increased cAMP production by 1180–2246%. The
adenylyl cyclase inhibitor MDL 12330A (10−4
m) inhibited GIP-induced glycerol production by >90%, and
reduced cAMP responses to basal. Preincubation of 3T3-L1 cells with
insulin inhibited glycerol responses to GIP, and the inhibitory effect
of insulin was blocked by the phosphatidylinositol 3′-kinase inhibitor,
wortmannin. It is concluded that GIP stimulates glycerol release in
3T3-L1 cells primarily via stimulation of cAMP production, and that
insulin antagonizes GIP-induced lipolysis in a wortmannin-sensitive
fashion. It is suggested that effects of GIP on fat metabolism
in vivo may depend upon the circulating insulin level,
and that meal-released GIP may elevate circulating fatty acids, thus
optimizing pancreatic β-cell responsiveness to stimulation by glucose
and GIP.